Oral Kandidoz
Oral kandidiyazis veya oral kandidoz,
ağız boşluğunun en yaygın, fırsatçı, fungal
enfeksiyonlarından biridir. Candida, sağlıklı
bireylerin normal ağız florasında mevcuttur.
Candida albicans insanlarda hem sağlıklı ağız
mukozasında hem de Oral kandidoz'da
bulunan en yaygın Candida türüdür. Oral
dokuları Candida enfeksiyonuna duyarlı hale
getiren çeşitli predispozan faktörler
bulunmaktadır. Bu durumun erken teşhisi ve
ağız hijyeninin sağlanması çok önemlidir. Oral
kandidozun klinik görünümü, çeşitli alt tiplerle
birlikte, beyaz veya eritematöz kandidoz olarak
sınıflandırılabilir. Bu patolojinin tedavisi için
çeşitli yaklaşımlar tanımlanmıştır. Tedaviler
uygun ağız hijyeni, topikal ajanlar ve sistemik
ilaçları içermektedir. Bu derlemede oral
kandidoz etyolojisi, predispozan faktörler,
klinik görünümü, teşhis ve tedavisinden
bahsedilecektir.
Oral Candidiasis
Oral candidiasis or oral
candidosis is one of the most common,
opportunistic, fungal infection of the oral
cavity. Candida is found in the normal oral flora
of healthy persons. Candida albicans is the most
common Candida species found in humans
both in healthy oral mucosa and oral
candidosis. There are several predisposing
factors that make oral tissues susceptible to
Candida infection. Early diagnosis of oral
candidosis and good oral hygiene are very
important. The clinical presentation of oral
candidosis can be classified as white or
erythematous candidosis, with several
subtypes. Various approaches have been
described for the treatment of this pathology.
Treatments include good oral hygiene, topical
agents, and systemic medications. In this
review, the etiology, predisposing factors,
clinical presentation, diagnosis and treatment
of oral candidosis will be discussed.
___
- 1. Millsop JW, Fazel N. Oral candidiasis. Clin
Dermatol. 2016;34(4):487-494.
- 2. Arendorf TM, Walker DM. The prevalence
and intra-oral distribution of Candida albicans
in man. Arch Oral Biol. 1980;25(1):1-10.
- 3. Singh A, Verma R, Murari M, Agrawal A.
Oral candidiasis: An overview. J Oral
Maxillofac Pathol. 2014;18(1):81-85.
- 4. Zegarelli DJ. Fungal infections of the oral
cavity. Otolaryngol Clin North Am.
1993;26(6):1069-1089.
- 5. Farah CS, Lynch N, McCullough MJ. Oral
fungal infections. Aust Dent J. 2010;55(1):48-
54.
- 6. McCullough MJ , ClemonsKV, StevensDA .
Molecular epidemiology of the global and
temporal diversity of Candida albicans. Clin
Infect Dis. 1999;29(5):1220-1225.
- 7. Reichart PA, Samaranayake LP , Philipsen
HP. Pathology and clinical correlates in oral
candidiasis and its variants. Oral Dis.
2000;6(2):85-91.
- 8. Astvad K,Johansen HK, Høiby
N,Steptoe P,Ishøy T . Oropharyngeal
Candidiasis in Palliative Care Patients in
Denmark. J Palliat Med. 2015;18(11):940-944.
- 9. Al-Karaawi ZM, Manfredi M,Waugh
AC, McCullough MJ, Jorge J, Scully C, Porter
SR . Molecular characterization of Candida spp.
isolated from the oral cavities of patients from
diverse clinical settings. Oral Microbiol
Immunol. 2002;17(1):44-49.
- 10. Cruz BB, Romo SA, López-Esqueda FJ
,Rosa-García E de la,HernándezRR, Sánchez-
VargasLO . Oral Candida isolates andfluconazole susceptibility patterns in older
Mexican women. Arch Gerontol Geriatr.
2016;65:204-210.
- 11. Farah CS, Ashman RB, Challacombe SJ.
Oral candidosis. Clin Dermatol.
2000;18(5):553-562.
- 12. Gonsalves WC, Chi AC, Neville BW.
Common Oral Lesions: Part I. Superficial
Mucosal Lesions. Am Fam Physician.
2007;75(4):501-507.
- 13. Bedair AA, Darwazeh AM,Al-Aboosi MM.
Oral Candida colonization and candidiasis in
patients with psoriasis. Oral Surg Oral Med Oral
Pathol Oral Radiol. 2012;114(5):610-615.
- 14. Schaller M , Borelli C , Korting HC , Hube
B. Hydrolytic enzymes as virulence factors of
Candida albicans.Mycoses. 2005;48(6):365-
377.
- 15. LinumaT ,Arai Y ,Abe Y, FukumotoM,
Fukui Y, Lwase T, Takebayashi T, Hirose N,
Gionhaku N, Komiyama Ket al. Denture
wearing during sleep doubles the risk of
pneumonia in the very elderly.J Dent Res.
2015;94(3):28-36.
- 16. SalvatoriO, PuriS, TatiS, EdgertonM.
Innate Immunity and Saliva in Candida
albicans-mediated Oral Diseases. J Dent Res.
2016;95(4):365-371.
- 17. Vila T, Rizk AM, Sultan AS, Jabra-Rizk
MA. The power of saliva: Antimicrobial and
beyond. PLOS Pathog. 2019;15(11):e1008058.
- 18. Khan SA, Fidel PL, Jr, Al Thunayyan A,
Varlotta S, Meiller TFet al. Impaired Histatin-
5 Levels and Salivary Antimicrobial Activity
against C. albicans in HIV Infected
Individuals.J AIDS Clin Res. 2013;4(193).
- 19. Tejani S, Sultan A, Stojanov I , Woo SB.
Candidal carriage predicts candidiasis during
topical immunosuppressive therapy: a
preliminary retrospective cohort study. Oral
Surg Oral Med Oral Pathol Oral Radiol.
2016;122(4):448-454.
- 20. Mun M,Yap T,Alnuaimi AD,Adams
GG,McCullough M. Oral candidal carriage in
asymptomatic patients. Aust Dent J.
2016;61(2):190-195.
- 21. RadM ,KakoieS,Niliye Brojeni F,PourdamghanN. Effect of Long-term Smoking
on Whole-mouth Salivary Flow Rate and Oral
Health. J Dent Res Dent Clin Dent Prospects.
2010;4(4):110-114.
- 22. Farah C, Balasubramaniam R, McCullough
MJ. Contemporary Oral Medicine. Switzerland:
Springer, 2019. 2409 p.
- 23. VidyaKM, Rao UK, Nittayananta W, Liu H
L,Owotade FJ. Oral mycoses and other
opportunistic infections in HIV: therapy and
emerging problems - a workshop report. Oral
Dis. 2016;22(1):158-165.
- 24. Samaranayake LP, Keung Leung W, JinJ.
Oral mucosal fungal infections. Periodontol
2000. 2009;49(1):39-59.
- 25. Warnakulasuriya S, Tilakaratna WM. Oral
Medicine & Pathology: A Guide to Diagnosis
and Management.Jaypee Brothers Medical
Publishers,2021.
- 26. GasparotoTH, Oliveira CE de, Vieira NA,
Porto VC, Gasparoto CT, Campanelli AP, Lara
VS et al. The pattern recognition receptors
expressed on neutrophils and the associated
cytokine profile from different aged patients
with Candida-related denture stomatitis. Exp
Gerontol. 2012;47(9):741-748.
- 27. Johnson DA, Yeh CK , Dodds MW. Effect
of donor age on the concentrations of histatins
in human parotid and submandibular/sublingual
saliva. Arch Oral Biol. 2000;45(9):731-740.
- 28. Villa T, Sultan AS,Montelongo-Jauregui
D,Jabra-Rizk MA. Oral Candidiasis: A Disease
of Opportunity. J fungi (Basel, Switzerland).
2020;6(1):15.
- 29. Apkan A, Morgan R. Oral candidiasis.
Postgrad Med J. 2002;78(922):455-459.
- 30. Sharon V, Fazel N. Oral candidiasis and
angular cheilitis. Dermatol Ther.
2010;23(3):230-242.
- 31. Muzyka BC. Oral fungal infections. Dent
Clin North Am. 2005;49(1):49-65.
- 32. Sitheeque MAM, Samaranayake LP.
Chronic hyperplastic candidosis/candidiasis
(candidal leukoplakia). Crit Rev Oral Biol
Med. 2003;14(4):253-267.
- 33. Patton LL. Oral lesions associated withhuman immunodeficiency virus disease. Dent
Clin North Am. 2013;57(4):673-698.
- 34. Ellepola AN, Samaranayake LP.
Inhalational and topical steroids, and oral
candidosis: a mini review. Oral Dis.
2001;7(4):211-216
- 35. Ellepola AN, Samaranayake LP. Oral
candidal infections and antimycotics. Crit Rev
Oral Biol Med. 2000;11(2):172-198.
- 36. Giannini PJ, Shetty K V. Diagnosis and
management of oral candidiasis. Otolaryngol
Clin North Am. 2011;44(1):231-240.
- 37. Barros SP, Altarawneh S, Bencharit S,
Loewy Z, Gendreau L, Offenbacher S, Denture
sore mouth. A possible etiology. British Dental
Journal. 2012;1(12):357-360.
- 38. Perić M, Živković R, Milić Lemić A,
Radunović M, Miličić B, Arsić Arsenijević V.
The severity of denture stomatitis as related to
risk factors and different Candida spp. Oral
Surg Oral Med Oral Pathol Oral Radiol.
2018;126(1):41-47.
- 39. Redman RS. Prevalence of geographic
tongue, fissured tongue, median rhomboid
glossitis, and hairy tongue among 3,611
Minnesota schoolchildren. Oral Surgery, Oral
Med Oral Pathol. 1970;30(3):390-395.
- 40. Appleton SS. Candidiasis: pathogenesis,
clinical characteristics, and treatment. J Calif
Dent Assoc. 2000;28(12):942-948.
- 41. Rose JA. Folic-acid deficiency as a cause
of angular cheilosis. Lancet (London,
England). 1971;2(7722):453-454
- 42. Odden K, Schenck K, Koppang H, Hurlen
B. Candidal infection of the gingiva in HIVinfected
persons. J Oral Pathol Med.
1994;23(4):178-183.
- 43. Velegraki A, Nicolatou O, Theodoridou M,
Mostrou G, Legakis NJ.Paediatric AIDS--
related linear gingival erythema: a form of
erythematous candidiasis? J Oral Pathol Med.
1999;28(4):178-182.
- 44. Taylor M, Raja A. Oral Candidiasis.
StatPearls. Published online July 25, 2021.
Accessed September 11, 2021.
https://www.ncbi.nlm.nih.gov/books/NBK545
282/
- 45. Williams DW, Lewis MA. Isolation and
identification of Candida from the oral cavity.
Oral Dis. 2000;6(1):3-11.
- 46. COMPAGNONI MA, SOUZA RF,
MARRA J, PERO AC, BARBOSA DB.
Relationship between Candida and nocturnal
denture wear: quantitative study. J Oral
Rehabil. 2007;34(8):600-605.
- 47. Kauffman CA, Jones PG. Candidiasis.Post
Grad Med. 2016;80(1):129-134.
- 48. Pappas PG, Kauffman CA, Andes D,
Benjamin DK Jr, Calandra TF, Edwards JE Jr,
Filler SG, Fisher JF, Kullberg BJ, Ostrosky-
Zeichner L, Reboli AC, Rex JH, Walsh TJ,
Sobel JD. Clinical Practice Guideline for the
Management of Candidiasis: Clin Infect
Dis.2009; 48(5): 503–535.
- 49. Balabanova M, Popova L, Tchipeva R.
Dyes in dermatology. Clin Dermatol.
2003;21(1):2-6.
- 50. Epstein JB. Antifungal therapy in
oropharyngeal mycotic infections. Oral Surg
Oral Med Oral Pathol. 1990;69(1):32-41.
- 51. Greenspan D. Treatment of oropharyngeal
candidiasis in HIV-positive patients. J Am
Acad Dermatol. 1994;31(3):51-55.
- 52. Hellfritzsch M, Pottegård A, Pedersen AJ,
Burghle A, Mouaanaki F, Hallas J, Grove EL,
Damkier P. Topical Antimycotics for Oral
Candidiasis in Warfarin Users. Basic Clin
Pharmacol Toxicol. 2017;120(4):368-372.
- 53. Dias AP, Samaranayake LP, Lee MT.
Miconazole lacquer in the treatment of denture
stomatitis: clinical and microbiological
findings in Chinese patients. Clin Oral
Investig. 1997;1(1):47-52.
- 54. Zhang LW, Fu JY, Hua H, Yan ZM.
Efficacy and safety of miconazole for oral
candidiasis: a systematic review and metaanalysis.
Oral Dis. 2016;22(3):185-195.
- 55. Stelzner A. F. C. Odds, Candida and
Candidosis, A Review and Bibliography
(Second Edition). J Basic Microbiol.
1990;30(5):382-383.
- 56. Gupta AK, Sauder DN, Shear NH.
Antifungal agents: an overview. Part I. J Am
Acad Dermatol. 1994;5(1):677-698
- 57. FDA Drug Safety Communication: FDA
limits usage of Nizoral (ketoconazole) oral
tablets due to potentially fatal liver injury and
risk of drug interactions and adrenal gland
problems | FDA. Accessed September 12,
2021. https://www.fda.gov/drugs/drug-safetyand-
availability/fda-drug-safetycommunication-
fda-limits-usage-nizoralketoconazole-
oral-tablets-due-potentially
- 58. Aleck KA, Bartley DL. Multiple
malformation syndrome following fluconazole
use in pregnancy: report of an additional
patient. Am J Med Genet. 1997;72(3):253-
256.
- 59. Barone JA, Koh JG, Bierman RH, Colaizzi
JL, Swanson KA, Gaffar MC, Moskovitz BL,
Mechlinski W, Van de Velde V. Food
interaction and steady-state pharmacokinetics
of itraconazole capsules in healthy male
volunteers. Antimicrob Agents Chemother.
1993;37(4):778-784.
- 60. Vazquez JA. Role of posaconazole in the
management of oropharyngeal and esophageal
candidiasis. Ther Clin Risk Manag.
2007;3(4):533-542.